Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bulk water protons in tissues serve as the fundamental source of signal in magnetic resonance imaging (MRI) due to their high abundance in biological systems (StatPearls, 2023). These protons are primarily located within water molecules (H2O) distributed across intracellular and extracellular compartments (NIH, 2022). In the context of pharmacology, bulk water protons are the primary target for diagnostic contrast agents, such as gadolinium-based contrast agents (GBCAs) and iron oxide nanoparticles (PubChem, 2024). These agents exert their effect by shortening the longitudinal (T1) and transverse (T2) relaxation times of nearby water protons through paramagnetic or superparamagnetic interactions (Journal of Magnetic Resonance Imaging, 2021). This modulation enhances the contrast between different tissue types or highlights pathological changes like inflammation, edema, or malignancy. Consequently, the behavior and distribution of bulk water protons are critical for diagnosing a wide range of conditions, including cardiovascular diseases, neurological disorders, and various cancers (Mayo Clinic, 2023).
Paramagnetic relaxation enhancement
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bulk water protons in tissues.